Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma
- PMID: 19349471
- PMCID: PMC2682471
- DOI: 10.1210/jc.2009-0344
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma
Comment on
-
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.J Clin Endocrinol Metab. 2009 Apr;94(4):1264-73. doi: 10.1210/jc.2008-1342. Epub 2008 Dec 16. J Clin Endocrinol Metab. 2009. PMID: 19088157
References
-
- Carr MC, Ayyobi AF, Murdoch SJ, Deeb SS, Brunzell JD 2002 Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler Thromb Vasc Biol 22:667–673 - PubMed
-
- Connelly PW, Maguire GF, Lee M, Little JA 1990 Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10:40–48 - PubMed
-
- Goldberg RB 2006 Impact of thiazolidenediones on serum lipoprotein levels. Curr Atheroscler Rep 8:397–404 - PubMed
-
- Zambon A, Hokanson JE, Brown BG, Brunzell JD 1999 Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 99:1959–1964 - PubMed
-
- Calabresi L, Franceschini G 1997 High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein. Curr Opin Lipidol 8:219–224 - PubMed